History
The Ph. Eur. Commission adopted its first finished product monograph containing a chemically defined active substance and adopted its strategy for the implementation of the ICH Q3D Guideline on Elemental impurities.
The Republic of Korea was granted observer status to the European Pharmacopoeia Convention and the ratification of the MEDICRIME Convention by the Republic of Guinea (the fifth to date) triggered the entry into force of the convention on 1 January 2016.
See the 2015 Annual Report.